BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 53 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,450 | -1.2% | 185,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $181,720 | -48.2% | 185,000 | -45.9% | 0.01% | -50.0% |
| Q1 2023 | $350,885 | +96562.5% | 342,000 | 0.0% | 0.01% | -7.7% |
| Q4 2022 | $363 | -99.9% | 342,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $339,000 | +17.7% | 342,000 | +17.5% | 0.01% | +30.0% |
| Q2 2022 | $288,000 | +19.5% | 291,000 | +20.7% | 0.01% | +42.9% |
| Q1 2022 | $241,000 | -4.4% | 241,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $252,000 | +236.0% | 241,000 | +239.4% | 0.01% | +75.0% |
| Q4 2019 | $75,000 | – | 71,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |